• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

AJW:GR

3.925 EUR 0.082 2.13%

As of 03:05:36 ET on 07/11/2014.

Snapshot for AnGes MG Inc (AJW)

Open: 3.970 Day's Range: 3.925 - 3.970 Volume: 0
Previous Close: 3.843 52wk Range: 2.374 - 10.562 1-Yr Rtn: -58.99%

Stock Chart for AJW

No chart data available.
  • AJW:GR 3.925
  • 1D
  • 1M
  • 1Y
3.843
Interactive AJW Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AJW

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (12/2014) -80.0000
Est. PEG Ratio -
Market Cap (M EUR) 127.19
Shares Outstanding (M) 32.40
30 Day Average Volume 127
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AJW

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for AJW

AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients. The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism. AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.

Ei YamadaPresident/CEOShunsuke SamiExecutive Vice President
Makoto SekiExecutive OfficerTakahiro NakazawaExecutive Officer
More Company Profile & Key Executives for AJW

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil